Jarrow Formulas Inc

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SAMe in Prevention of Oxaliplatin-associated Liver Injury	5-fluorouracil toxicity, Chemically-Induced Disorders, Chemically-Induced Liver Toxicity, Digestive System Diseases, Digestive System Neoplasms, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, cardiovascular disorder, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, drug-induced liver injury, hepatic veno-occlusive disease, intestinal disorder, liver disorder, neoplasm, poisoning, rectal disorder, vascular disorder	Not yet recruiting	Phase 2	2026-09-30		NCT06258525
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT	Adnexal Diseases, Chemically-Induced Disorders, Chemotherapy-Related Cognitive Impairment, Cognition Disorders, Cognitive Dysfunction, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, cognitive disorder, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, psychiatric disorder	Recruiting	Phase 1 / Phase 2	2026-07-17		NCT04520139

Clinical trials